Sonata develops a doctor-led longevity healthcare membership that integrates whole-genome sequencing, DNA methylation analysis, over 140 blood biomarkers, and real-time wearable telemetry into a single longitudinal wellness record. The company charges a direct-to-consumer $2,500 annual founding membership fee, which is eligible for HSA/FSA funds. Led by CEO Sagan Schultz, Sonata plans to expand its proprietary clinical AI platform and scale physician-led digital care networks. It intends to accelerate consumer membership onboarding across launch hubs in New York, San Francisco, and Los Angeles. The company emerged from stealth concurrent with announcing its $7M seed financing.

Total raised

$7M

Funding rounds

1

Latest round

Seed

Latest activity

Jul 2026